Privo Technologies, Inc., ("Privo") today announced that enrollment has been completed for Arm 2 of the CLN-004 clinical trial evaluating PRV211, and that the study met its primary safety endpoint.

Marti Cifuentes' win percentage is compared to every single Leicester City manager of the Srivaddhanaprabha era ...

The AACE has updated its guidance on obesity and adiposity-based chronic disease to reflect a focus on improving overall ...

January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences ...

One of the most common client questions—“How long does a tick need to feed?”—doesn’t have a single answer. Transmission timing varies widely depending on the pathogen and the tick species involved, ...

A man in Quang Tri was stunned to learn his fatigue and muscle pain were caused by parasitic cysts, likely linked to his ...

The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.

Kolkata's Institute of Breast Disease launched two mobile apps, ME App for breast self-examination and ChemoCare for ...

If you are newly diagnosed with mesothelioma, it is important that you learn all you can about the disease and your treatment options. In general, how your mesothelioma is treated will depend on the ...

An panel of health care experts discussed the evolution of wearables in patient care during Newsweek's latest webinar.

In a randomized trial of men with a single suspicious lesion on MRI, targeted perilesional biopsy matched standard targeted and systematic biopsy for detecting clinically significant prostate cancer - ...